ADM and Sepsis: Several biomarkers have been proposed as tools to distinguish sepsis from other non-inflammatory syndromes, such as the procalcitonin (PCT), or the Mid-regional pro-adrenomedullin (ADM), a peptide-like procalcitonin belonging to the calcitonin peptide family, to obtain early the differentiation between inflammation and infection processes21,22.